Prescribing drugs of dependence in general practice
Part C1 - Opioids
Last revised: 02 Jun 2020
ACSQH
Australian Commission for Safety and Quality in Health Care
ADEC
Australian Drug Evaluation Committee
AIHW
Australian Institute of Health and Welfare
ANZCA
Australian and New Zealand College of Anaesthetists
CBT
Cognitive behavioural therapy
CDCP
Centers for Disease Control and Prevention
CI
confidence interval
CIPN
chemotherapy-induced peripheral neuropathy
DDD
defined daily dose
DVA
Department of Veterans’ Affairs
DSM-5
Diagnostic and statistical manual of mental disorders (5th edition)
ED
emergency department
GRADE
Grading of Recommendations Assessment, Development and Evaluation
GP
General practitioner
FDA
Food and Drug Administration
HIV
human immunodeficiency virus
IASP
International Association for the Study of Pain
IM
intramuscular
IV
intravenous
MBS
Medicare Benefits Schedule
MOH
medication-overuse headache
NHS
National Health Service
NNT
number needed to treat
NPS
National Prescribing Service
NSAID
non-steroidal anti-inflammatory drug
OIH
opioid-induced hyperalgesia
ÖMPQ
Örebro musculoskeletal pain questionnaire
ORT
opioid replacement therapy
OSA
obstructive sleep apnoea
OTC
over-the-counter
PBS
Pharmaceutical Benefits Scheme
PDMP
prescription drug monitoring program
PEG
Pain, Enjoyment, General activity (tool)
PHN
Primary Health Network
PRN
pro re nata (as needed)
PSIS
Prescription Shopping Information Service
PSP
Prescription Shopping Programme
RCT
randomised controlled trial
RPBS
Repatriation Pharmaceutical Benefits Scheme
RTPM
real-time prescription monitoring
S4
Schedule 4
S8
Schedule 8
S100
Section 100 (highly specialised drugs)
SC
subcutaneous
SNRI
Serotonin-norepinephrine reuptake inhibitor
SDM
shared decision making
serotonin noradrenaline reuptake inhibitor
SSRI
selective serotonin reuptake inhibitor
SUD
Substance use disorder
TCAs
Tricyclic antidepressants
TdP
Torsades de Pointes
TGA
Therapeutic Goods Administration
UDS
urine drug screen
UDT
urine drug test
Advertising